{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T21:03:18Z","timestamp":1785358998094,"version":"3.55.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgpath.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Pathology Clinics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.path.2026.02.005","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:59:21Z","timestamp":1780631961000},"page":"357-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ancillary Studies in the Diagnosis and Classification of Barrett Esophagus"],"prefix":"10.1016","volume":"19","author":[{"given":"Danielle A.","family":"Hutchings","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Montgomery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00419-3","article-title":"Global burden and epidemiology of Barrett oesophagus and oesophageal cancer","volume":"18","author":"Thrift","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.14309\/ajg.0000000000001680","article-title":"Diagnosis and management of Barrett\u2019s esophagus: an updated ACG guideline","volume":"117","author":"Shaheen","year":"2022","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1053\/j.gastro.2024.03.019","article-title":"AGA clinical practice guideline on endoscopic eradication therapy of Barrett\u2019s esophagus and related neoplasia","volume":"166","author":"Rubenstein","year":"2024","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1053\/hupa.2001.23510","article-title":"Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation","volume":"32","author":"Montgomery","year":"2001","journal-title":"Hum Pathol"},{"issue":"7","key":"10.1016\/j.path.2026.02.005_bib5","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1365-2559.2007.02706.x","article-title":"Grading of dysplasia in Barrett\u2019s oesophagus: substantial interobserver variation between general and gastrointestinal pathologists","volume":"50","author":"Kerkhof","year":"2007","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.path.2026.02.005_bib6","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1111\/j.1572-0241.2000.03348.x","article-title":"The diagnosis of low-grade dysplasia in Barrett\u2019s esophagus and its implications for disease progression","volume":"95","author":"Skacel","year":"2000","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.path.2026.02.005_bib7","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.cgh.2021.04.032","article-title":"Magnitude and time-trend analysis of postendoscopy esophageal adenocarcinoma: a systematic review and meta-analysis","volume":"20","author":"Sawas","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib8","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1053\/j.gastro.2025.09.012","article-title":"AGA clinical practice guideline on surveillance of Barrett\u2019s esophagus","volume":"169","author":"Wani","year":"2025","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.path.2026.02.005_bib9","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13000-022-01273-w","article-title":"p53 immunostaining pattern is a useful surrogate marker for TP53 gene mutations","volume":"17","author":"Sung","year":"2022","journal-title":"Diagn Pathol"},{"issue":"61","key":"10.1016\/j.path.2026.02.005_bib10","doi-asserted-by":"crossref","first-page":"104123","DOI":"10.18632\/oncotarget.22021","article-title":"Pattern of p53 protein expression is predictive for survival in chemoradiotherapy-naive esophageal adenocarcinoma","volume":"8","author":"Ten Kate","year":"2017","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.path.2026.02.005_bib11","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1097\/PAS.0000000000001713","article-title":"Cytoplasmic pattern p53 immunoexpression in pelvic and endometrial carcinomas with TP53 mutation involving nuclear localization domains: an uncommon but potential diagnostic pitfall with clinical implications","volume":"45","author":"Rabban","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib12","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/cjp2.53","article-title":"Optimized p53 immunohistochemistry is an accurate predictor of TP53 mutation in ovarian carcinoma: p53 immunohistochemistry predictsTP53mutation status","volume":"2","author":"K\u00f6bel","year":"2016","journal-title":"J Pathol Clin Res"},{"issue":"3","key":"10.1016\/j.path.2026.02.005_bib13","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/his.12956","article-title":"Dysplasia in Barrett\u2019s oesophagus: p53 immunostaining is more reproducible than haematoxylin and eosin diagnosis and improves overall reliability, while grading is poorly reproducible","volume":"69","author":"Kaye","year":"2016","journal-title":"Histopathology"},{"issue":"7","key":"10.1016\/j.path.2026.02.005_bib14","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/his.14642","article-title":"The utility of P53 immunohistochemistry in the diagnosis of Barrett\u2019s esophagus with indefinite for dysplasia","volume":"80","author":"Januszewicz","year":"2022","journal-title":"Histopathology"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib15","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1111\/his.13462","article-title":"Improved diagnostic stratification of digitised Barrett\u2019s oesophagus biopsies by p53 immunohistochemical staining","volume":"72","author":"van der Wel","year":"2018","journal-title":"Histopathology"},{"issue":"12","key":"10.1016\/j.path.2026.02.005_bib16","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1097\/PAS.0000000000001162","article-title":"Refined criteria for separating low-grade dysplasia and nondysplastic Barrett Esophagus reduce equivocal diagnoses and improve prediction of patient outcome: a 10-Year review","volume":"42","author":"Waters","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.path.2026.02.005_bib17","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1136\/gutjnl-2014-307278","article-title":"Barrett\u2019s oesophagus patients with low-grade dysplasia can be accurately risk-stratified after histological review by an expert pathology panel","volume":"64","author":"Duits","year":"2015","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.path.2026.02.005_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/PAS.0000000000001066","article-title":"Improved progression prediction in Barrett\u2019s esophagus with low-grade dysplasia using specific histologic criteria","volume":"42","author":"Ten Kate","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/hupa.2001.23511","article-title":"Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study","volume":"32","author":"Montgomery","year":"2001","journal-title":"Hum Pathol"},{"issue":"5","key":"10.1016\/j.path.2026.02.005_bib20","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1097\/PAS.0000000000000819","article-title":"The use of ancillary stains in the diagnosis of Barrett esophagus and Barrett esophagus-associated dysplasia: recommendations from the Rodger C. haggitt Gastrointestinal Pathology Society","volume":"41","author":"Srivastava","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"10.1016\/j.path.2026.02.005_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/his.14828","article-title":"Aberrant p53 expression is associated with neoplastic progression in Barrett oesophagus diagnosed as indefinite for dysplasia","volume":"82","author":"Chen","year":"2023","journal-title":"Histopathology"},{"issue":"3","key":"10.1016\/j.path.2026.02.005_bib22","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/his.14143","article-title":"Use of p53 immunohistochemistry in conjunction with routine histology improves risk stratification of patients with Barrett\u2019s oesophagus during routine clinical care","volume":"77","author":"Tokuyama","year":"2020","journal-title":"Histopathology"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib23","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1093\/gastro\/gov045","article-title":"Expression of p53 predicts risk of prevalent and incident advanced neoplasia in patients with Barrett\u2019s esophagus and epithelial changes indefinite for dysplasia","volume":"4","author":"Horvath","year":"2016","journal-title":"Gastroenterol Rep (Oxf)"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib24","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/0016-5085(93)91058-P","article-title":"p53 protein accumulation in Barrett\u2019s metaplasia, dysplasia, and carcinoma: a follow-up study","volume":"105","author":"Younes","year":"1993","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.path.2026.02.005_bib25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1572-0241.2001.03851.x","article-title":"p53 protein overexpression in low grade dysplasia (LGD) in Barrett\u2019s esophagus: immunohistochemical marker predictive of progression","volume":"96","author":"Weston","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"10.1016\/j.path.2026.02.005_bib26","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1136\/gutjnl-2012-303594","article-title":"Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett\u2019s oesophagus","volume":"62","author":"Kastelein","year":"2013","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.path.2026.02.005_bib27","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/j.gastro.2021.10.038","article-title":"Abnormal TP53 predicts risk of progression in patients with Barrett\u2019s esophagus regardless of a diagnosis of dysplasia","volume":"162","author":"Redston","year":"2022","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/his.14848","article-title":"Defining an abnormal p53 immunohistochemical stain in Barrett\u2019s oesophagus-related dysplasia: a single-positive crypt is a sensitive and specific marker of dysplasia","volume":"82","author":"Tomaszewski","year":"2023","journal-title":"Histopathology"},{"issue":"2","key":"10.1016\/j.path.2026.02.005_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/his.15442","article-title":"The future is now: advancing p53 immunohistochemistry in Barrett\u2019s oesophagus and its implication for the everyday pathologist","volume":"88","author":"Chornenkyy","year":"2026","journal-title":"Histopathology"},{"issue":"8","key":"10.1016\/j.path.2026.02.005_bib30","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1177\/10668969231157304","article-title":"Aberrant p53 expression in gastric biopsies and resection specimens following neoadjuvant chemoradiation: a diagnostic pitfall","volume":"31","author":"Hutchings","year":"2023","journal-title":"Int J Surg Pathol"},{"issue":"8","key":"10.1016\/j.path.2026.02.005_bib31","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/s41379-022-01056-0","article-title":"Utility of ancillary studies in the diagnosis and risk assessment of Barrett\u2019s esophagus and dysplasia","volume":"35","author":"Choi","year":"2022","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1158\/1055-9965.EPI-15-1164","article-title":"A tissue systems pathology assay for high-risk Barrett\u2019s esophagus","volume":"25","author":"Critchley-Thorne","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"10.1016\/j.path.2026.02.005_bib33","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1158\/1055-9965.EPI-16-0640","article-title":"A tissue systems pathology test detects abnormalities associated with prevalent high-grade dysplasia and esophageal cancer in Barrett\u2019s esophagus","volume":"26","author":"Critchley-Thorne","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.path.2026.02.005_bib34","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000244","article-title":"Independent validation of a tissue systems pathology assay to predict future progression in nondysplastic Barrett\u2019s esophagus: a spatial-temporal analysis","volume":"11","author":"Frei","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib35","doi-asserted-by":"crossref","first-page":"843","DOI":"10.14309\/ajg.0000000000000556","article-title":"Independent blinded validation of a tissue systems pathology test to predict progression in patients with Barrett\u2019s esophagus","volume":"115","author":"Davison","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib36","doi-asserted-by":"crossref","first-page":"675","DOI":"10.14309\/ajg.0000000000001037","article-title":"Tissue systems pathology test objectively risk stratifies Barrett\u2019s esophagus patients with low-grade dysplasia","volume":"116","author":"Frei","year":"2021","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib37","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MCG.0000000000002040","article-title":"The tissue systems pathology test objectively risk-stratifies patients with Barrett\u2019s esophagus: results from a multicenter US clinical experience study: results from a multicenter US clinical experience study","volume":"59","author":"Villa","year":"2025","journal-title":"J Clin Gastroenterol"},{"issue":"5","key":"10.1016\/j.path.2026.02.005_bib38","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1053\/j.gastro.2023.07.029","article-title":"The tissue systems pathology test outperforms pathology review in risk stratifying patients with low-grade dysplasia","volume":"165","author":"Khoshiwal","year":"2023","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.path.2026.02.005_bib39","doi-asserted-by":"crossref","DOI":"10.1093\/dote\/doy099","article-title":"Wide-area transepithelial sampling with computer-assisted 3-dimensional analysis (WATS) markedly improves detection of esophageal dysplasia and Barrett\u2019s esophagus: analysis from a prospective multicenter community-based study","volume":"32","author":"Smith","year":"2019","journal-title":"Dis Esophagus"},{"issue":"2","key":"10.1016\/j.path.2026.02.005_bib40","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.gie.2017.07.039","article-title":"Increased detection of Barrett\u2019s esophagus-associated neoplasia using wide-area trans-epithelial sampling: a multicenter, prospective, randomized trial","volume":"87","author":"Vennalaganti","year":"2018","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"10.1016\/j.path.2026.02.005_bib41","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.gie.2023.03.032","article-title":"Benefit of adjunctive wide-area transepithelial sampling with 3-dimensional computer-assisted analysis plus forceps biopsy based on Barrett\u2019s esophagus segment length","volume":"98","author":"Trindade","year":"2023","journal-title":"Gastrointest Endosc"},{"issue":"10","key":"10.1016\/j.path.2026.02.005_bib42","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.14309\/ajg.0000000000002818","article-title":"Adjunctive use of wide-area transepithelial sampling-3D in patients with symptomatic gastroesophageal reflux increases detection of Barrett\u2019s esophagus and dysplasia","volume":"119","author":"Shaheen","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib43","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1177\/2050640617746298","article-title":"Increased detection of Barrett\u2019s esophagus and esophageal dysplasia with adjunctive use of wide-area transepithelial sample with three-dimensional computer-assisted analysis (WATS)","volume":"6","author":"Gross","year":"2018","journal-title":"United Eur Gastroenterol J"},{"issue":"12","key":"10.1016\/j.path.2026.02.005_bib44","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000107","article-title":"Adjunctive yield of wide-area transepithelial sampling for dysplasia detection after advanced imaging and random biopsies in Barrett\u2019s esophagus","volume":"10","author":"Raphael","year":"2019","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"10.1016\/j.path.2026.02.005_bib45","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1055\/a-1949-9542","article-title":"Wide-area transepithelial sampling with computer-assisted analysis to detect high grade dysplasia and cancer in Barrett\u2019s esophagus: a multicenter randomized study","volume":"55","author":"van Munster","year":"2023","journal-title":"Endoscopy"},{"issue":"3","key":"10.1016\/j.path.2026.02.005_bib46","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.gie.2021.09.014","article-title":"Progression of Barrett\u2019s esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis","volume":"95","author":"Shaheen","year":"2022","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"10.1016\/j.path.2026.02.005_bib47","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.gtc.2015.02.015","article-title":"Genetic and epigenetic alterations in Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"44","author":"Kaz","year":"2015","journal-title":"Gastroenterol Clin N Am"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib48","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.14309\/ajg.0000000000003030","article-title":"Validation of an epigenetic prognostic assay to accurately risk-stratify patients with Barrett esophagus","volume":"120","author":"Laun","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.path.2026.02.005_bib49","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.14309\/ajg.0000000000003367","article-title":"Spatiotemporal study of a risk-stratification epigenetic-based biomarker assay in patients with Barrett esophagus","volume":"120","author":"Laun","year":"2025","journal-title":"Am J Gastroenterol"},{"issue":"424","key":"10.1016\/j.path.2026.02.005_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao5848","article-title":"Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett\u2019s esophagus","volume":"10","author":"Moinova","year":"2018","journal-title":"Sci Transl Med"},{"issue":"11","key":"10.1016\/j.path.2026.02.005_bib51","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.14309\/ajg.0000000000002850","article-title":"Multicenter, prospective trial of nonendoscopic biomarker-driven detection of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"119","author":"Moinova","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.path.2026.02.005_bib52","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/s41395-018-0107-7","article-title":"Highly discriminant methylated DNA markers for the non-endoscopic detection of Barrett\u2019s esophagus","volume":"113","author":"Iyer","year":"2018","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"10.1016\/j.path.2026.02.005_bib53","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.14309\/ajg.0000000000000656","article-title":"Accurate nonendoscopic detection of Barrett\u2019s esophagus by methylated DNA markers: a multisite case control study: a multisite case control study","volume":"115","author":"Iyer","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"10.1016\/j.path.2026.02.005_bib54","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.gie.2021.03.937","article-title":"Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett\u2019s esophagus in a multisite case-control study","volume":"94","author":"Iyer","year":"2021","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"10.1016\/j.path.2026.02.005_bib55","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/1078-0432.CCR-18-3696","article-title":"Methylation biomarker panel performance in EsophaCap cytology samples for diagnosing Barrett\u2019s esophagus: a prospective validation study","volume":"25","author":"Wang","year":"2019","journal-title":"Clin Cancer Res"},{"issue":"10","key":"10.1016\/j.path.2026.02.005_bib56","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.14309\/ajg.0000000000003323","article-title":"Discovery of methylated DNA biomarkers for potential nonendoscopic detection of Barrett\u2019s esophagus and esophageal adenocarcinoma","volume":"120","author":"Kalra","year":"2025","journal-title":"Am J Gastroenterol"}],"container-title":["Surgical Pathology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187591812600019X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187591812600019X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:27:22Z","timestamp":1785356842000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187591812600019X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S187591812600019X"],"URL":"https:\/\/doi.org\/10.1016\/j.path.2026.02.005","relation":{},"ISSN":["1875-9181"],"issn-type":[{"value":"1875-9181","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ancillary Studies in the Diagnosis and Classification of Barrett Esophagus","name":"articletitle","label":"Article Title"},{"value":"Surgical Pathology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.path.2026.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}